Skip to main content
SpringerLink
Log in

Reactive Oxygen Species (ROS): Modulator of Response to Cancer Therapy in Non-Small-Cell Lung Carcinoma (NSCLC)

  • Chapter
  • First Online:
Oxidative Stress in Lung Diseases

Abstract

Oxidative stress, caused by an imbalance between oxidants and antioxidants, is implicated in the etiology and progression of many types of cancer including lung cancer. The most common type of lung cancer, NSCLC, is the leading cause of cancer-related deaths worldwide. The lung tissue is particularly vulnerable to oxidative stress because of its direct interface with ambient air which exposes it to a variety of oxidants. In order to protect itself from oxidative stress, lung tissue is equipped with a robust endogenous antioxidant defense system mostly controlled by the redox-sensitive transcription factor Nrf2 which is negatively regulated by Keap1 protein. Lung cancer cells are reported to contain increased levels of ROS. However, administration of antioxidants has failed to show any obvious effectiveness in the prevention or cure of lung cancer. On the other hand, a prooxidant approach has been proposed to successfully kill cancer cells by generating ROS. Cancer cells, owing to their high basal ROS, are considered to be more vulnerable to the toxic effect of exogenous ROS-generating agents as opposed to normal cells. A major challenge in this mode of therapy is the acquisition of drug resistance in cancer cells. This is attributed to an elevation in the antioxidant system in cancer cells, leading to “redox adaptation,” which facilitates survival under enhanced oxidative stress. Incidentally, lung cancer cells have been reported to exhibit constitutive overexpression of Nrf2. Therefore, impairment of the Nrf2/Keap1 antioxidant pathway might be a promising strategy to control NSCLC. In this chapter, the importance of ROS as a signaling molecule in regulating some of the hallmark feature of cancer, such as proliferation, apoptosis, angiogenesis, metastasis, etc., is discussed. Furthermore, the various ROS-modulating therapeutic approaches to treat NSCLC presently under investigation at experimental and clinical setting are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Li M, Zhang X, Hu K, Shi M, Dong G, Li D, Zhang P (2018) Prognostic role of snail in lung cancer: protocol for a systematic review. Medicine (Baltimore) 97(28):e11539

    Article  Google Scholar 

  2. Yang P (2009) Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol Biol 471:469–486

    Article  PubMed  PubMed Central  Google Scholar 

  3. Borghetti P, Bonù ML, Roca E, Pedretti S, Salah E, Baiguini A, Greco D, Triggiani L, Maddalo M, Levra NG, Alongi F, Magrini SM, Mm B (2018) Radiotherapy and tyrosine kinase inhibitors in stage IV non-small cell lung cancer: real-life experience. In Vivo 32:159–164

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Zappa C, Mousa SA (2016) Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res 5(3):288–300

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Tsvetkova E, Goss GD (2012) Drug resistance and its significance for treatment decisions in non-small-cell lung cancer. Curr Oncol 19(Suppl 1):S45–S51

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Villegas L, Stidham T, Nozik-Grayck E (2014) Oxidative stress and therapeutic development in lung diseases. J Pulm Respir Med 4(4):194

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kumari S, Badana AK, Mohan GM, Shailender G, Malla R (2018) Reactive oxygen species: a key constituent in cancer survival. Biomark Insights 13:1177271918755391

    Article  PubMed  PubMed Central  Google Scholar 

  8. Luanpitpong S, Talbott SJ, Rojanasakul Y, Nimmannit U, Pongrakhananon V, Wang L, Chanvorachote P (2010) Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem 285(50):38832–38840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Misthos P, Katsaragakis S, Milingos N, Kakaris S, Sepsas E, Athanassiadi K, Theodorou D, Skottis I (2005) Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation. Eur J Cardiothorac Surg 527:379–383

    Article  Google Scholar 

  10. Chung-man Ho J, Zheng S, Comhair SA, Farver C, Erzurum SC (2001) Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 61:8578–8585

    CAS  PubMed  Google Scholar 

  11. Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579–591

    Article  CAS  PubMed  Google Scholar 

  12. Panieri E, Santoro MM (2016) ROS homeostasis and metabolism: a dangerous liaison in cancer cells. Cell Death Dis 7(6):e2253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Martinez-Useros J, Li W, Cabeza-Morales M, Garcia-Foncillas J (2017) Oxidative stress: a new target for pancreatic cancer prognosis and treatment. J Clin Med 6(3):pii: E29

    Article  CAS  Google Scholar 

  14. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7(2):97–110

    Article  CAS  PubMed  Google Scholar 

  15. Cheresh P, Kim SJ, Tulasiram S, Kamp DW (2013) Oxidative stress and pulmonary fibrosis. Biochim Biophys Acta 1832(7):1028–1040

    Article  CAS  PubMed  Google Scholar 

  16. Bernard K, Hecker L, Luckhardt TR, Cheng G, Thannickal VJ (2014) NADPH oxidases in lung health and disease. Antioxid Redox Signal 20(17):2838–2853

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Carnesecchi S, Pache JC, Barazzone-Argiroffo C (2012) NOX enzymes: potential target for the treatment of acute lung injury. Cell Mol Life Sci 69(14):2373–2385

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Phys Lung Cell Mol Phys 279(6):L1005–L1028

    CAS  Google Scholar 

  19. Han M, Zhang T, Yang L, Wang Z, Ruan J, Chang X (2016) Association between NADPH oxidase (NOX) and lung cancer: a systematic review and meta-analysis. J Thorac Dis 8(7):1704–1711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kinnula VL, Crapo JD, Raivio KO (1995) Generation and disposal of reactive oxygen metabolites in the lung. Lab Investig 73:3–19

    CAS  PubMed  Google Scholar 

  21. Polimeni M, Gazzano E (2014) Is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy? Front Pharmacol 5:286

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Cook IA, Pass HI, Iype SN, Friedman N, Degraff W, Russo A, Mitchell JB (1991) Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res 51:4287–4294

    CAS  PubMed  Google Scholar 

  23. Oberli-Schrammli AE, Joncourt F, Stadler M, Altermatt HJ, Buser K, Ris HB, Schmid U, Cerny T (1994) Parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA alkyltransferase and P-glycoprotein as indicators of drug resistance in tumor and normal lung of patients with lung cancer. Int J Cancer 59:629–636

    Article  CAS  PubMed  Google Scholar 

  24. Tong YH, Zhang B, Fan Y, Lin NM (2015) Keap1–Nrf2 pathway: a promising target towards lung cancer prevention and therapeutics. Chron Dis Transl Med 1(3):175–186

    Google Scholar 

  25. Milkovic L, Zarkovic N, Saso L (2017) Controversy about pharmacological modulation of Nrf2 for cancer therapy. Redox Biol 12:727–732

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270(5234):296–299

    Article  CAS  PubMed  Google Scholar 

  27. Poole LB, Nelson KJ (2008) Discovering mechanisms of signaling-mediated cysteine oxidation. Curr Opin Chem Biol 12(1):18–24

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Adachi M, Fischer EH, Ihle J, Imai K, Jirik F, Neel B, Pawson T, Shen S, Thomas M, Ullrich A, Zhao Z (1996) Mammalian SH2-containing protein tyrosine phosphatases. Cell 85(1):15

    Article  CAS  PubMed  Google Scholar 

  29. Meng TC, Fukada T, Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9(2):387–399

    Article  CAS  PubMed  Google Scholar 

  30. Schlessinger J (2002) Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110(6):669–672

    Article  CAS  PubMed  Google Scholar 

  31. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275(21):16023–16029

    Article  CAS  PubMed  Google Scholar 

  32. Niture SK, Jaiswal AK (2012) Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem 287(13):9873–9886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Morgan MJ, Liu ZG (2011) Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res 21(1):103–115

    Article  CAS  PubMed  Google Scholar 

  34. Djavaheri-Mergny M, Javelaud D, Wietzerbin J, Besançon F (2004) NF-kappaB activation prevents apoptotic oxidative stress via an increase of both thioredoxin and MnSOD levels in TNFalpha-treated Ewing sarcoma cells. FEBS Lett 578(1–2):111–115

    Article  CAS  PubMed  Google Scholar 

  35. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C, Torti FM, Torti SV, Franzoso G (2004) Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119(4):529–542

    Article  CAS  PubMed  Google Scholar 

  36. Xia C, Hu J, Ketterer B, Taylor JB (1996) The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem J 313(Pt 1):155–161

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG (1994) Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci U S A 91(13):5987–5991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Redza-Dutordoir M, Averill-Bates DA (2016) Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 1863(12):2977–2992

    Article  CAS  PubMed  Google Scholar 

  39. Circu ML, Aw TY (2012) Glutathione and modulation of cell apoptosis. Biochim Biophys Acta 1823(10):1767–1777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749–762

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Orrenius S, Gogvadze V, Zhivotovsky B (2015) Calcium and mitochondria in the regulation of cell death. Biochem Biophys Res Commun 460:72–81

    Article  CAS  PubMed  Google Scholar 

  42. Pallepati P, Averill-Bates DA (2011) Mild thermotolerance induced at 40 degrees C protects HeLa cells against activation of death receptor-mediated apoptosis by hydrogen peroxide. Free Radic Biol Med 50:667–679

    Article  CAS  PubMed  Google Scholar 

  43. Zhuang S, Demirs JT, Kochevar IE (2000) p38 mitogen-activated protein kinase mediates bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen but not by hydrogen peroxide. J Biol Chem 275:25939–25948

    Article  CAS  PubMed  Google Scholar 

  44. Zhang AY, Yi F, Jin S, Xia M, Chen QZ, Gulbins E, Li PL (2007) Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 9:817–828

    Article  CAS  PubMed  Google Scholar 

  45. Ushio-Fukai M, Nakamura Y (2008) Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett 266(1):37–52

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker TP (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 95:11715–11720

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, Görlach A (2006) NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 8(9–10):1473–1484

    Article  CAS  PubMed  Google Scholar 

  48. Peshavariya H, Dusting GJ, Jiang F, Halmos LR, Sobey CG, Drummond GR, Selemidis S (2009) NADPH oxidase isoform selective regulation of endothelial cell proliferation and survival. Naunyn Schmiedeberg’s Arch Pharmacol 380(2):193–204

    Article  CAS  Google Scholar 

  49. Komatsu D, Kato M, Nakayama J, Miyagawa S, Kamata T (2008) NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 27(34):4724–4732

    Article  CAS  PubMed  Google Scholar 

  50. Ikeda S, Yamaoka-Tojo M, Hilenski L, Patrushev NA, Anwar GM, Quinn MT, Ushio-Fukai M (2005) IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. Arterioscler Thromb Vasc Biol 25(11):2295–2300

    Article  CAS  PubMed  Google Scholar 

  51. Polytarchou C, Hatziapostolou M, Papadimitriou E (2005) Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J Biol Chem 280(49):40428–40435

    Article  CAS  PubMed  Google Scholar 

  52. Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF, Csiszar K, Hendrix MJ, Kirschmann DA (2005) Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 65(24):11429–11436

    Article  CAS  PubMed  Google Scholar 

  53. Hawk MA, Schafer ZT (2018) Mechanisms of redox metabolism and cancer cell survival during extracellular matrix detachment. J Biol Chem 293(20):7531–7537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P (2005) Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 25(15):6391–6403

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Inumaru J, Nagano O, Takahashi E, Ishimoto T, Nakamura S, Suzuki Y, Niwa S, Umezawa K, Tanihara H, Saya H (2009) Molecular mechanisms regulating dissociation of cell-cell junction of epithelial cells by oxidative stress. Genes Cells 14(6):703–716

    Article  CAS  PubMed  Google Scholar 

  56. Davison CA, Durbin SM, Thau MR, Zellmer VR, Chapman SE, Diener J, Wathen C, Leevy WM, Schafer ZT (2013) Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix. Cancer Res 73:3704–3715

    Article  CAS  PubMed  Google Scholar 

  57. Kamarajugadda S, Cai Q, Chen H, Nayak S, Zhu J, He M, Jin Y, Zhang Y, Ai L, Martin SS, Tan M, Lu J (2013) Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis. Cell Death Dis 4:e504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ, Morrison SJ (2015) Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527:186–191

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Peiris-Pagès M, Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2015) Metastasis and oxidative stress: are antioxidants a metabolic driver of progression? Cell Metab 22(6):956–958

    Article  PubMed  CAS  Google Scholar 

  60. Weng MS, Chang JH, Hung WY, Yang YC, Chien MH (2018) The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance. J Exp Clin Cancer Res 37:61

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  61. Filosto S, Khan EM, Tognon E, Becker C, Ashfaq M, Ravid T, Goldkorn T (2011) EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization. PLoS One 6(8):e23240

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Zhang L, Li J, Hu J, Li D, Wang X, Zhang R, Zhang H, Shi M, Chen H (2017) Cigarette smoke extract induces EGFR-TKI resistance via promoting EGFR signaling pathway and ROS generation in NSCLC cell lines. Lung Cancer 109:109–116

    Article  PubMed  Google Scholar 

  63. Truong TH, Carroll KS (2012) Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation. Biochemistry 51(50):9954–9965

    Article  CAS  PubMed  Google Scholar 

  64. Leung EL, Fan XX, Wong MP, Jiang ZH, Liu ZQ, Yao XJ, Lu LL, Zhou YL, Yau LF, Tin VP, Liu L (2016) Targeting tyrosine kinase inhibitor-resistant non-small cell lung cancer by inducing epidermal growth factor receptor degradation via methionine 790 oxidation. Antioxid Redox Signal 24(5):263–279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Krall EB, Wang B, Munoz DM, Ilic N, Raghavan S, Niederst MJ, Yu K, Ruddy DA, Aguirre AJ, Kim JW, Redig AJ, Gainor JF, Williams JA, Asara JM, Doench JG, Janne PA, Shaw AT, McDonald Iii RE, Engelman JA, Stegmeier F, Schlabach MR, Hahn WC (2017) KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer. elife 6:e18970

    Article  PubMed  PubMed Central  Google Scholar 

  66. Leone A, Roca MS, Ciardiello C, Terranova-Barberio M, Vitagliano C, Ciliberto G, Mancini R, Di Gennaro E, Bruzzese F, Budillon A (2015) Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway. Free Radic Biol Med 89:287–299

    Article  CAS  PubMed  Google Scholar 

  67. Li YL, Hu X, Li QY, Wang F, Zhang B, Ding K, Tan BQ, Lin NM, Zhang C (2018) Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy. Mol Med Rep 18(4):3882–3890

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Nie P, Hu W, Zhang T, Yang Y, Hou B, Zou Z (2015) Synergistic induction of erlotinib-mediated apoptosis by resveratrol in human non-small-cell lung cancer cells by down-regulating survivin and up-regulating PUMA. Cell Physiol Biochem 35:2255–2271

    Article  CAS  PubMed  Google Scholar 

  69. Kobayashi S, Boggon TJ, Dayaram T, Jänne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B (2005) EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 352(8):786–792

    Article  CAS  PubMed  Google Scholar 

  70. Okon IS, Coughlan KA, Zhang M, Wang Q, Zou MH (2015) Gefitinib-mediated reactive oxygen species (ROS) instigates mitochondrial dysfunction and drug resistance in lung cancer cells. J Biol Chem 290(14):9101–9110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Hong SW, Park NS, Noh MH, Shim JA, Ahn BN, Kim YS, Kim D, Lee HK, Hur DY (2017) Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway. Lung Cancer 106:115–124

    Article  PubMed  Google Scholar 

  72. Wang YC, Wu DW, Wu TC, Wang L, Chen CY, Lee H (2018) Dioscin overcome TKI resistance in EGFR-mutated lung adenocarcinoma cells via down-regulation of tyrosine phosphatase SHP2 expression. Int J Biol Sci 14(1):47–56

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. Matkar SS, Wrischnik LA, Hellmann-Blumberg U (2008) Production of hydrogen peroxide and redox cycling can explain how sanguinarine and chelerythrine induce rapid apoptosis. Arch Biochem Biophys 477(1):43–52

    Article  CAS  PubMed  Google Scholar 

  74. Ozben T (2007) Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96(9):2181–2196

    Article  CAS  PubMed  Google Scholar 

  75. Wang J, Yi J (2008) Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 7(12):1875–1884

    Article  CAS  PubMed  Google Scholar 

  76. Schumacker PT (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10:175–176

    Article  CAS  PubMed  Google Scholar 

  77. Wang JP, Hsieh CH, Liu CY, Lin KH, Wu PT, Chen KM, Fang K (2017) Reactive oxygen species-driven mitochondrial injury induces apoptosis by teroxirone in human non-small cell lung cancer cells. Oncol Lett 14(3):3503–3509

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Wangpaichitr M, Wu C, Li YY, Nguyen DJM, Kandemir H, Shah S, Chen S, Feun LG, Prince JS, Kuo MT, Savaraj N (2017) Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer. Oncotarget 8(30):49275–49292

    Article  PubMed  PubMed Central  Google Scholar 

  79. Wang S, Hu Y, Yan Y, Cheng Z, Liu T (2018) Sotetsuflavone inhibits proliferation and induces apoptosis of A549 cells through ROS-mediated mitochondrial-dependent pathway. BMC Complement Altern Med 18(1):235

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Liu X, Chen L, Liang T, Tian XD, Liu Y, Zhang T (2017) Withaferin A induces mitochondrial-dependent apoptosis in non-small cell lung cancer cells via generation of reactive oxygen species. J BUON 22(1):244–250

    PubMed  Google Scholar 

  81. Kang N, Jian JF, Cao SJ, Zhang Q, Mao YW, Huang YY, Peng YF, Qiu F, Gao XM (2016) Physalin A induces G2/M phase cell cycle arrest in human non-small cell lung cancer cells: involvement of the p38 MAPK/ROS pathway. Mol Cell Biochem 415(1–2):145–155

    Article  CAS  PubMed  Google Scholar 

  82. Rao PC, Begum S, Jahromi MA, Jahromi ZH, Sriram S, Sahai M (2016) Cytotoxicity of withasteroids: withametelin induces cell cycle arrest at G2/M phase and mitochondria-mediated apoptosis in non-small cell lung cancer A549 cells. Tumour Biol 37(9):12579–12587

    Article  CAS  PubMed  Google Scholar 

  83. Wondrak GT (2007) NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. Free Radic Biol Med 43:178–190

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Magda D, Miller RA (2006) Motexafin gadolinium: a novel redox active drug for cancer therapy. Semin Cancer Biol 16:466–476

    Article  CAS  PubMed  Google Scholar 

  85. Lu LY, Ou N, Lu QB (2013) Antioxidant induces DNA damage, cell death and mutagenicity in human lung and skin normal cells. Sci Rep 3:3169

    Article  PubMed  PubMed Central  Google Scholar 

  86. Baskar R, Dai J, Wenlong N, Yeo R, Yeoh KW (2014) Biological response of cancer cells to radiation treatment. Front Mol Biosci 1:24

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  87. Goldberg Z, Lehnert BE (2002) Radiation-induced effects in unirradiated cells: a review and implications in cancer. Int J Oncol 21(2):337–349

    CAS  PubMed  Google Scholar 

  88. Park H, Jeong YJ, Han NK, Kim JS, Lee HJ (2018) Oridonin enhances radiation-induced cell death by promoting DNA damage in non-small cell lung cancer cells. Int J Mol Sci 19(8):pii: E2378

    Article  CAS  Google Scholar 

  89. Lee JC, Krochak R, Blouin A, Kanterakis S, Chatterjee S, Arguiri E, Vachani A, Solomides CC, Cengel KA, Christofidou-Solomidou M (2009) Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury. Cancer Biol Ther 8(1):47–53

    Article  CAS  PubMed  Google Scholar 

  90. Christofidou-Solomidou M, Tyagi S, Pietrofesa R, Dukes F, Arguiri E, Turowski J, Grieshaber PA, Solomides CC, Cengel KA (2012) Radioprotective role in lung of the flaxseed lignan complex enriched in the phenolic secoisolariciresinol diglucoside (SDG). Radiat Res 178(6):568–580

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Cho HJ, Ahn KC, Choi JY, Hwang SG, Kim WJ, Um HD, Park JK (2015) Luteolin acts as a radiosensitizer in non-small cell lung cancer cells by enhancing apoptotic cell death through activation of a p38/ROS/caspase cascade. Int J Oncol 46(3):1149–1158

    Article  CAS  PubMed  Google Scholar 

  92. Sun M, Dong P, Chen Y, Li Y, Gao K, Hu B (2017) Coroglaucigenin enhances the radiosensitivity of human lung cancer cells through Nrf2/ROS pathway. Oncotarget 8(20):32807–32820

    PubMed  PubMed Central  Google Scholar 

  93. Sun X, Wang Q, Wang Y, Du L, Xu C, Liu Q (2016) Brusatol enhances the radiosensitivity of A549 cells by promoting ROS production and enhancing DNA damage. Int J Mol Sci 17(7):997

    Article  PubMed Central  CAS  Google Scholar 

  94. Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn J, Song JY (2012) An effective strategy for increasing the radiosensitivity of human lung cancer cells by blocking Nrf2-dependent antioxidant responses. Free Radic Biol Med 53(4):807–816

    Article  PubMed  CAS  Google Scholar 

  95. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780–783

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Okon IS, Zou MH (2015) Mitochondrial ROS and cancer drug resistance: implications for therapy. Pharmacol Res 100:170–174

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Shankar M, Willcutts D, Roth JA, Ramesh R (2010) Drug resistance in lung cancer. Lung Cancer (Auckl) 1:23–36

    Google Scholar 

  98. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, Herman JG, Baylin SB, Sidransky D, Gabrielson E, Brock MV, Biswal S (2006) Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 3(10):e420

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  99. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, Shibata T, Yamamoto M, Hirohashi S (2008) Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 68:1303–1309

    Article  CAS  PubMed  Google Scholar 

  100. Zhou S, Ye W, Shao Q, Zhang M, Liang J (2013) Nrf2 is a potential therapeutic target in radioresistance in human cancer. Crit Rev Oncol Hematol 88(3):706–715

    Article  PubMed  Google Scholar 

  101. Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, Kikuchi N, Satoh H, Sakamoto T, Hizawa N, Itoh K, Yamamoto M (2009) Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res 15(10):3423–3432

    Article  CAS  PubMed  Google Scholar 

  102. Kim HR, Kim S, Kim EJ, Park JH, Yang SH, Jeong ET, Park C, Youn MJ, So HS, Park R (2008) Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin. Lung Cancer 60:47–56

    Article  PubMed  Google Scholar 

  103. Degese MS, Mendizabal JE, Gandini NA, Gutkind JS, Molinolo A, Hewitt SM, Curino AC, Coso OA, Facchinetti MM (2012) Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer 77:168–175

    Article  PubMed  Google Scholar 

  104. Yang Y, Deng Y, Chen X, Zhang J, Chen Y, Li H, Wu Q, Yang Z, Zhang L, Liu B (2018) Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism. Toxicol Lett 295:88–98

    Article  CAS  PubMed  Google Scholar 

  105. Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, Zhang DD (2011) Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci U S A 108(4):1433–1438

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Eli, Edythe L, Cancer Genome Atlas Research Network (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489(7417):519–525

    Article  CAS  Google Scholar 

  107. Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330(15):1029–1035

    Article  Google Scholar 

  108. van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H (2000) EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst 92(12):977–986

    Article  PubMed  Google Scholar 

  109. Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12(12):931–947

    Article  CAS  PubMed  Google Scholar 

  110. Montero AJ, Diaz-Montero CM, Deutsch Y, Hurley J, Koniaris LG, Rumboldt T, Yasir S, Jorda M, Garret-Mayer E, Avisar E, Slingerland J, Silva O, Welsh C, Schuhwerk K, Seo P, Pegram MD, Glück S (2012) Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer. Breast Cancer Res Treat 132:215–223

    Article  CAS  PubMed  Google Scholar 

  111. Townsend DM, He L, Hutchens S, Garrett TE, Pazoles CJ, Tew KD (2008) NOV-002, a glutathione disulfide mimetic, as a modulator of cellular redox balance. Cancer Res 68:2870–2877

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF (2009) Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. Int J Radiat Oncol Biol Phys 73:1069–1076

    Article  CAS  PubMed  Google Scholar 

  113. Liou GY, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44(5):479–496

    Article  CAS  PubMed  Google Scholar 

  114. Gupta A, Srivastava S, Prasad R, Natu SM, Mittal B, Negi MP, Srivastava AN (2010) Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response. Respirology 15(2):349–356

    Article  PubMed  Google Scholar 

  115. Hoffer LJ, Robitaille L, Zakarian R, Melnychuk D, Kavan P, Agulnik J, Cohen V, Small D, Miller WH Jr (2015) High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial. PLoS One 10(4):e0120228

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  116. Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO (2014) Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 6:221ra15

    Article  PubMed  CAS  Google Scholar 

  117. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150–1155

    Article  CAS  PubMed  Google Scholar 

  118. Villegas L, Stidham T, Nozik-Grayck E (2014) Oxidative stress and therapeutic development in lung diseases. J Pulm Respir Med 4(4):pii: 194

    Article  Google Scholar 

  119. Glasauer A, Chandel NS (2014) Targeting antioxidants for cancer therapy. Biochem Pharmacol 92(1):90–101

    Article  CAS  PubMed  Google Scholar 

  120. Watson J (2013) Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol 3(1):120144

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  121. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, Hirohashi S (2008) Cancer-related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A 105(36):13568–13573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA, Corvalan AH, Biswal S, Swisher SG, Bekele BN, Minna JD, Stewart DJ, Wistuba II (2010) Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res 16(14):3743–3753

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F, Watson WH, Gabrielson E, Feinstein E, Biswal S (2008) RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res 68:7975–7984

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The author wishes to thank Dr. Deba Prasad Mandal, Assistant Professor, Dept. of Zoology, West Bengal State University, for his valuable comments and inputs in the manuscript.

Author information

Authors and Affiliations

  1. Department of Zoology, West Bengal State University, Kolkata, West Bengal, India

    Shamee Bhattacharjee

Authors
  1. Shamee Bhattacharjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India

    Sajal Chakraborti

  2. Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

    Narasimham L. Parinandi

  3. Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India

    Rita Ghosh

  4. Apollo Hospitals Educational & Research Foundation (AHERF), Indraprastha Apollo Hospitals, New Delhi, Delhi, India

    Nirmal K. Ganguly

  5. Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, West Bengal, India

    Tapati Chakraborti

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bhattacharjee, S. (2020). Reactive Oxygen Species (ROS): Modulator of Response to Cancer Therapy in Non-Small-Cell Lung Carcinoma (NSCLC). In: Chakraborti, S., Parinandi, N., Ghosh, R., Ganguly, N., Chakraborti, T. (eds) Oxidative Stress in Lung Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-32-9366-3_16

Download citation

Publish with us

Policies and ethics

Search

Navigation